282
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Virtue ethics and the United Kingdom (UK) Vaccine Damage Payment Scheme (VDPS)

ORCID Icon
 

ABSTRACT

I contend that virtue ethics provides the best ethical justification for vaccination programmes, and associated payment schemes for vaccine damaged individuals (which have been adopted in twenty-four countries and one province). Virtue ethics justifies vaccination programmes, as they contribute to the common good, and associated payment schemes, as they demonstrate compassion, justice and prudence in response to virtuous vaccination decisions by citizens. I also argue that the virtues of maturity and prudence justify voluntary vaccinations. I utilise several virtues to analyse, and suggest reforms to, the United Kingdom’s (UK) Vaccine Damage Payment Scheme (VDPS). I also compare the UK VDPS with the schemes that have been adopted in other states, in particular the Vaccine Injury Compensation Programme (VICP) which has been adopted within the United States (US).

Acknowledgments

I would like to thank Professor Emma Cave, Dr Richard Craven, Professor Sara Fovargue, Dr Arushi Garg, Professor Tsachi Keren-Paz, Professor Anna Kirkland, Professor Heidi Larson and Dr Stephanie Pywell for their helpful and thorough comments regarding earlier drafts/presentations of this paper. I am also grateful to Dr Daniel Franchini for providing me with copies of the judgments from the Italian cases cited within this paper. I would also like to thank the editors and the reviewer of the Journal of Social Welfare and Family Law.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Notes

1. Austria, China, Denmark, Finland, France, Germany, Hungary, Iceland, Italy, Japan, Latvia, Luxembourg, Nepal, New Zealand, Norway, UK, US, Russia, Taiwan, Thailand, Slovenia, South Korea, Sweden, Switzerland, Vietnam and the province of Quebec in Canada.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.